APA (7th ed.) Citation

KE, B., WY, L., MP, F., K, S., G, L., & NA, H. (2016). High CYP2C19 phenotypic variability in gastrointestinal cancer patients. Cancer chemotherapy and pharmacology, 77(1), 195. https://doi.org/10.1007/s00280-015-2923-4

Chicago Style (17th ed.) Citation

KE, Burns, Lo WY, Findlay MP, Sharples K, Laking G, and Helsby NA. "High CYP2C19 Phenotypic Variability in Gastrointestinal Cancer Patients." Cancer Chemotherapy and Pharmacology 77, no. 1 (2016): 195. https://doi.org/10.1007/s00280-015-2923-4.

MLA (9th ed.) Citation

KE, Burns, et al. "High CYP2C19 Phenotypic Variability in Gastrointestinal Cancer Patients." Cancer Chemotherapy and Pharmacology, vol. 77, no. 1, 2016, p. 195, https://doi.org/10.1007/s00280-015-2923-4.